Notification
No new Notification messages
Niva Bupa Health Insurance IPO is Open!
Apply for the Niva Bupa Health Insurance IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
laurus labs limited stock

LAURUS LABS LIMITED Share Price

499.35 4.39 (0.88%)
Nov 08 2024 03:30 PM Pharmaceuticals NSE: LAURUSLABS

LAURUS LABS LIMITED Share Price Update

As of the latest trading session, LAURUS LABS LIMITED share price is currently at 499.35, which is up by 4.39 from its previous closing. Today, the stock has fluctuated between 494.15 and 507.00. Over the past year, LAURUS LABS LIMITED has achieved a return of 34.36 %. In the last month alone, the return has been 13.68 %. Read More...

LAURUS LABS LIMITED Performance

Day Range

Low494.15 High507.00
499.35

52 Week Range

Low 360.85 High 518.00
499.35

LAURUS LABS LIMITED Share Price

19234

540222

LAURUSLABS

img img img img
No Data Available

Open Price

496.50

Prev. Close

494.95

Volume (Shares)

3843439.00

Total traded value

19192.21

Upper Circuit

544.40

Lower Circuit

445.45

Note: The current prices & values are delayed, Login to your account for live updates.

LAURUS LABS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 26913.26
PE Ratio (TTM) 114.45
Book Value / Share 79.19
Beta 0.88
ROE 5.41%
EPS (TTM) 4.36
Dividend Yield 0.16%
Net Profit Qtr (Cr) 42.44

LAURUS LABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1184.85
Operating Expense 1138.65
Net Profit 42.44
Net Profit Margin (%) 3.58
Earnings Per Share (EPS) 0.79
EBITDA 193.72
Effective Tax Rate (%) 26.94
Particulars JUN 2024 (Values in Cr)
Revenue 1116.93
Operating Expense 1087.43
Net Profit 28.78
Net Profit Margin (%) 2.57
Earnings Per Share (EPS) 0.53
EBITDA 170.69
Effective Tax Rate (%) 25.82
Particulars MAR 2024 (Values in Cr)
Revenue 1414.52
Operating Expense 1274.30
Net Profit 121.32
Net Profit Margin (%) 8.57
Earnings Per Share (EPS) 2.25
EBITDA 295.20
Effective Tax Rate (%) 26.16
Particulars DEC 2023 (Values in Cr)
Revenue 1132.19
Operating Expense 1086.21
Net Profit 42.64
Net Profit Margin (%) 3.76
Earnings Per Share (EPS) 0.79
EBITDA 181.10
Effective Tax Rate (%) 24.79
Particulars SEP 2023 (Values in Cr)
Revenue 1158.03
Operating Expense 1100.72
Net Profit 46.67
Net Profit Margin (%) 4.03
Earnings Per Share (EPS) 0.87
EBITDA 186.41
Effective Tax Rate (%) 26.16
Particulars MAR 2024 (Values in Cr)
Revenue 4812.39
Operating Expense 4558.34
Net Profit 223.70
Net Profit Margin (%) 4.64
Earnings Per Share (EPS) 4.15
EBITDA 797.30
Effective Tax Rate (%) 25.79
Particulars MAR 2023 (Values in Cr)
Revenue 5773.45
Operating Expense 4737.97
Net Profit 760.38
Net Profit Margin (%) 13.17
Earnings Per Share (EPS) 14.14
EBITDA 1497.71
Effective Tax Rate (%) 27.68
Particulars MAR 2022 (Values in Cr)
Revenue 4707.04
Operating Expense 3753.18
Net Profit 750.09
Net Profit Margin (%) 15.93
Earnings Per Share (EPS) 13.97
EBITDA 1306.75
Effective Tax Rate (%) 23.10
Particulars MAR 2021 (Values in Cr)
Revenue 4768.72
Operating Expense 3521.41
Net Profit 956.11
Net Profit Margin (%) 20.04
Earnings Per Share (EPS) 17.85
EBITDA 1537.19
Effective Tax Rate (%) 24.98
Particulars MAR 2020 (Values in Cr)
Revenue 2797.34
Operating Expense 2498.67
Net Profit 267.05
Net Profit Margin (%) 9.54
Earnings Per Share (EPS) 5.01
EBITDA 576.04
Effective Tax Rate (%) 12.29
Particulars MAR 2024 (Values in Cr)
Book Value / Share 76.28
ROE % 4.13
ROCE % 6.31
Total Debt to Total Equity 0.56
EBITDA Margin 15.95
Particulars MAR 2023 (Values in Cr)
Book Value / Share 74.96
ROE % 21.56
ROCE % 21.78
Total Debt to Total Equity 0.51
EBITDA Margin 26.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.37
ROE % 27.99
ROCE % 24.59
Total Debt to Total Equity 0.55
EBITDA Margin 29.13
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.41
ROE % 45.05
ROCE % 37.78
Total Debt to Total Equity 0.59
EBITDA Margin 32.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 165.11
ROE % 15.34
ROCE % 13.60
Total Debt to Total Equity 0.64
EBITDA Margin 20.15
Particulars MAR 2024 (Values in Cr)
Book Value / Share 78.06
ROE % 5.41
ROCE % 7.34
Total Debt to Total Equity 0.46
EBITDA Margin 16.57
Particulars MAR 2023 (Values in Cr)
Book Value / Share 75.31
ROE % 20.43
ROCE % 21.62
Total Debt to Total Equity 0.45
EBITDA Margin 25.94
Particulars MAR 2022 (Values in Cr)
Book Value / Share 63.05
ROE % 24.59
ROCE % 22.71
Total Debt to Total Equity 0.50
EBITDA Margin 27.76
Particulars MAR 2021 (Values in Cr)
Book Value / Share 50.54
ROE % 42.23
ROCE % 37.11
Total Debt to Total Equity 0.54
EBITDA Margin 32.23
Particulars MAR 2020 (Values in Cr)
Book Value / Share 169.84
ROE % 15.68
ROCE % 13.86
Total Debt to Total Equity 0.60
EBITDA Margin 20.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 141.65
Total Assets 8387.03
Total Liabilities 8387.03
Total Equity 4115.57
Share Outstanding 538965858
Price to Book Ratio 5.02
Return on Assets (%) 1.91
Return on Capital (%) 2.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 48.46
Total Assets 7660.40
Total Liabilities 7660.40
Total Equity 4048.66
Share Outstanding 538650925
Price to Book Ratio 3.89
Return on Assets (%) 10.31
Return on Capital (%) 13.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 75.94
Total Assets 6968.04
Total Liabilities 6968.04
Total Equity 3359.05
Share Outstanding 537359335
Price to Book Ratio 9.36
Return on Assets (%) 11.87
Return on Capital (%) 16.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 48.46
Total Assets 5750.69
Total Liabilities 5750.69
Total Equity 2600.70
Share Outstanding 536602385
Price to Book Ratio 7.16
Return on Assets (%) 17.10
Return on Capital (%) 24.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.74
Total Assets 3750.32
Total Liabilities 3750.32
Total Equity 1769.77
Share Outstanding 106914499
Price to Book Ratio 1.90
Return on Assets (%) 6.80
Return on Capital (%) 9.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 42.92
Total Assets 7667.48
Total Liabilities 7667.48
Total Equity 4207.05
Share Outstanding 538965858
Price to Book Ratio 5.02
Return on Assets (%) 2.91
Return on Capital (%) 3.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.70
Total Assets 6957.96
Total Liabilities 6957.96
Total Equity 4056.82
Share Outstanding 538650925
Price to Book Ratio 3.89
Return on Assets (%) 10.92
Return on Capital (%) 13.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 40.56
Total Assets 6608.53
Total Liabilities 6608.53
Total Equity 3388.21
Share Outstanding 537359335
Price to Book Ratio 9.36
Return on Assets (%) 11.35
Return on Capital (%) 14.98
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 38.78
Total Assets 5625.19
Total Liabilities 5625.19
Total Equity 2712.24
Share Outstanding 536602385
Price to Book Ratio 7.16
Return on Assets (%) 16.99
Return on Capital (%) 23.31
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.93
Total Assets 3739.36
Total Liabilities 3739.36
Total Equity 1815.80
Share Outstanding 106914499
Price to Book Ratio 1.90
Return on Assets (%) 7.14
Return on Capital (%) 9.73
Particulars MAR 2024 (Values in Cr)
Net Income 236.36
Cash from Operations 770.26
Cash from Investing -822.42
Cash from Financing 249.83
Net change in Cash 93.10
Free Cash Flow 1448.57
Particulars MAR 2023 (Values in Cr)
Net Income 1108.94
Cash from Operations 1279.39
Cash from Investing -996.06
Cash from Financing -26.64
Net change in Cash -28.80
Free Cash Flow 2269.55
Particulars MAR 2022 (Values in Cr)
Net Income 1083.85
Cash from Operations 1093.37
Cash from Investing -914.34
Cash from Financing 30.26
Net change in Cash 27.02
Free Cash Flow 1970.21
Particulars MAR 2021 (Values in Cr)
Net Income 1301.11
Cash from Operations 961.50
Cash from Investing -940.99
Cash from Financing 254.70
Net change in Cash 46.71
Free Cash Flow 1650.27
Particulars MAR 2020 (Values in Cr)
Net Income 293.61
Cash from Operations 387.06
Cash from Investing -221.13
Cash from Financing -127.66
Net change in Cash -1.37
Free Cash Flow 609.25
Particulars MAR 2024 (Values in Cr)
Net Income 301.47
Cash from Operations 756.52
Cash from Investing -756.74
Cash from Financing 139.41
Net change in Cash 41.21
Free Cash Flow 1123.84
Particulars MAR 2023 (Values in Cr)
Net Income 1051.43
Cash from Operations 1149.68
Cash from Investing -735.27
Cash from Financing -185.19
Net change in Cash -38.91
Free Cash Flow 1891.52
Particulars MAR 2022 (Values in Cr)
Net Income 975.41
Cash from Operations 989.31
Cash from Investing -836.61
Cash from Financing 15.19
Net change in Cash 1.55
Free Cash Flow 1750.76
Particulars MAR 2021 (Values in Cr)
Net Income 1274.63
Cash from Operations 920.51
Cash from Investing -899.68
Cash from Financing 243.13
Net change in Cash 37.90
Free Cash Flow 1517.06
Particulars MAR 2020 (Values in Cr)
Net Income 304.48
Cash from Operations 384.13
Cash from Investing -216.83
Cash from Financing -127.48
Net change in Cash 0.37
Free Cash Flow 602.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.67 38.10 3.27 449.61 35.27 / 77.70
BLISS GVS PHARMA LTD 124.15 15.54 1.29 1307.32 92.25 / 148.95
CIPLA LTD 1591.75 27.85 4.53 128549.00 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 336.10 0.00 3.42 989.18 144.45 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.67 88.89 11.15 449.61 35.27 / 77.70
AMRUTAJAN HEALTH LTD 706.95 47.99 7.08 2043.84 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 7317.65 139.65 25.69 18294.13 4050.15 / 8139.85
BLISS GVS PHARMA LTD 124.15 16.17 1.27 1307.32 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 496.20
  • 26 Days 478.20
  • 10 Days 490.20
  • 50 Days 474.80
  • 12 Days 485.80
  • 100 Days 462.40
  • 20 Days 483.60
  • 200 Days 417.40
495.70
PIVOT
First Resistance 501.70
Second Resistance 508.45
Third Resistance 514.45
First Support 488.95
Second Support 482.95
Third Support 476.20
RSI 65.04
MACD 7.59
Commodity Channel Index (CCI) 115.55
ADX 16.95
Williams % R -11.50

Over 1 Month

down

13.68

Over 3 Months

down

15.65

Over 6 Months

down

15.03

Over 1 Year

down

34.36

Over 3 Years

down

0.14

Over 5 Years

down

46.81

LAURUS LABS LIMITED Future

Future: Price

28 Nov
499.40
26 Dec
501.80
30 Jan
513.30
25 May
0 100 200 300 400 500 600

Discount/Premium

28 Nov
0.05
26 Dec
2.45
30 Jan
13.95
25 May
0 1 2 3 4 5 6 7

Active Calls

500.0
4829
510.0
2316
520.0
2163
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

500.0
1386
480.0
772
490.0
750
25 Jul
0 500 1000 1500 2000 2500

LAURUS LABS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
38.49
Promoter Holdings
27.17
FII
26.08
DII
8.24
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
M/s. Nsn Holdings (represented By Its Managing Partner, Dr. Satyanarayana Chava) Shareholding of Promoter and Promoter Group 1.2412674E8 23.02
New World Fund Inc Public Shareholding 3.5030909E7 6.5
Smallcap World Fund, Inc Public Shareholding 2.2072758E7 4.09
Anukar Projects Private Limited Public Shareholding 1.7483609E7 3.24
Life Insurance Corporation Of India Public Shareholding 1.4560251E7 2.7
Sbi Large & Midcap Fund Public Shareholding 1.3634393E7 2.53
Chunduru Venkata Lakshmana Rao Shareholding of Promoter and Promoter Group 1.3450145E7 2.49
Amansa Holdings Private Limited Public Shareholding 1.1522317E7 2.14
Kotak Funds - India Midcap Fund Public Shareholding 7471471.0 1.39
Akash Bhanshali Public Shareholding 7151700.0 1.33
M/s. Leven Holdings (represented By Its Managing Partner, Mr. Venkata Ravi Kumar Vantaram) Shareholding of Promoter and Promoter Group 6705000.0 1.24
Barclays Wealth Trustees India Private Limited Public Shareholding 6169184.0 1.14
Vanguard Total International Stock Index Fund Public Shareholding 5410831.0 1.0
Venkata Ravi Kumar Vantaram Shareholding of Promoter and Promoter Group 1000000.0 0.19
Krishnaveni Vasireddi Shareholding of Promoter and Promoter Group 201397.0 0.04
Hymavathi Vantaram Shareholding of Promoter and Promoter Group 225000.0 0.04
Rama Suryadevara Shareholding of Promoter and Promoter Group 170000.0 0.03
Narasimha Rao Suryadevara Shareholding of Promoter and Promoter Group 147500.0 0.03
Chava Narasimha Rao Shareholding of Promoter and Promoter Group 119675.0 0.02
Nagamani Thokala Shareholding of Promoter and Promoter Group 100000.0 0.02
Kamala Kommana Shareholding of Promoter and Promoter Group 100000.0 0.02
Sekhar Babu Chunduru Shareholding of Promoter and Promoter Group 100000.0 0.02
Chandrakanth Chereddi Shareholding of Promoter and Promoter Group 42000.0 0.01
Krishna Chaitanya Chava Shareholding of Promoter and Promoter Group 20699.0 0.0
Soumya Chava Shareholding of Promoter and Promoter Group 10440.0 0.0
Chava Naga Rani Shareholding of Promoter and Promoter Group 0.0 0.0
Satyanarayana Chava Shareholding of Promoter and Promoter Group 0.0 0.0

LAURUS LABS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-11-02 0.4 Interim 2023-11-02 Equity shares 2023-05-10 1.2 Interim 2 2023-05-10 Equity shares 2022-11-03 0.8 Interim 2022-11-04 Equity shares 2022-05-10 1.2 Interim 2 2022-05-11 Equity shares 2021-11-17 0.8 Interim 2021-11-18 Equity shares 2021-05-11 0.8 Interim 3 2021-05-12 Equity shares 2021-02-08 0.4 Interim 2 2021-02-09 Equity shares 2020-11-10 0.8 Interim 2020-11-11 Equity shares 2020-07-01 1.0 Final 2020-07-03 Equity shares 2020-03-23 1.5 Interim 2020-03-25 Equity shares 2019-07-03 1.5 Final 2019-07-05 Equity shares 2018-06-28 1.5 Final 2018-07-02 Equity shares 2017-07-06 1.5 Final 2017-07-10 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2020-09-29 10.0 2.0 2020-09-30

Learn More About Stocks

About LAURUS LABS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by LAURUS LABS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Laurus Labs Ltd?

Answer Field

The share price of Laurus Labs Ltd for NSE is ₹ 499.35 and for BSE is ₹ 499.

What is the Market Cap of Laurus Labs Ltd?

Answer Field

The market cap of Laurus Labs Ltd for NSE is ₹ 2,69,13.26 Cr. and for BSE is ₹ 2,68,94.40 Cr. as of now.

What is the 52 Week High and Low of Laurus Labs Ltd?

Answer Field

The 52 Week High and Low of Laurus Labs Ltd for NSE is ₹ 518.00 and ₹ 360.85 and for BSE is ₹ 517.90 and ₹ 358.70.

How to Buy Laurus Labs Ltd share?

Answer Field

You can trade in Laurus Labs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Laurus Labs Ltd?

Answer Field

The 1 year returns on the stock has been 34.36%.

What is the Current Share Price of Laurus Labs Ltd?

Answer Field

Laurus Labs Ltd share price is for NSE ₹ 499.35 & for BSE ₹ 499 as on Nov 08 2024 03:30 PM.

What is the Market Cap of Laurus Labs Ltd Share?

Answer Field

The market cap of Laurus Labs Ltd for NSE ₹ 2,69,13.26 & for BSE ₹ 2,68,94.40 as on Nov 08 2024 03:30 PM.

What is the P/E Ratio of Laurus Labs Ltd Share?

Answer Field

As on Nov 08 2024 03:30 PM the price-to-earnings (PE) ratio for Laurus Labs Ltd share is 114.45.

What is the PB ratio of Laurus Labs Ltd Share?

Answer Field

As on Nov 08 2024 03:30 PM, the price-to-book (PB) ratio for Laurus Labs Ltd share is 79.19.

How to Buy Laurus Labs Ltd Share?

Answer Field

You can trade in Laurus Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Laurus Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Laurus Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Laurus Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader